SPRY vs. PG
SPRY (Silverback Therapeutics Inc) and PG (The Procter & Gamble Company) are both stocks. SPRY operates in Biotechnology (Healthcare), while PG operates in Household & Personal Products (Consumer Defensive). Over the past 5 years, SPRY returned -28.53%/yr vs 2.97%/yr for PG. Their 0.03 correlation means their historical movements had little consistent relationship.
Performance
SPRY vs. PG - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, SPRY achieves a -53.13% return, which is significantly lower than PG's 3.41% return.
SPRY
- 1D
- 6.43%
- 1M
- -36.21%
- 6M
- -46.99%
- YTD
- -53.13%
- 1Y
- -68.22%
- 3Y*
- -8.08%
- 5Y*
- -28.53%
- 10Y*
- —
- ALL TIME*
- -25.54%
PG
- 1D
- 0.33%
- 1M
- -3.54%
- 6M
- -3.94%
- YTD
- 3.41%
- 1Y
- -0.94%
- 3Y*
- 0.34%
- 5Y*
- 2.97%
- 10Y*
- 8.30%
- ALL TIME*
- 10.08%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $1.28B | $1.27B | $1.30B | |
| $17.38M | $14.89M | $16.09M |
SPRY vs. PG - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
SPRY Silverback Therapeutics Inc | -53.13% | 10.43% | 92.52% | -35.76% | 28.08% | -85.63% | 59.79% |
PG The Procter & Gamble Company | 3.41% | -12.26% | 17.25% | -0.86% | -5.05% | 20.52% | 1.31% |
Correlation
The correlation between SPRY and PG is 0.03, meaning there was essentially no consistent relationship between their historical price movements. Each responded to its own set of market drivers.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.03 |
Correlation (3Y) Balances recent behavior with more history. | 0.02 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.05 |
Correlation (All Time) Calculated using the full available price history since Dec 4, 2020 | 0.03 |
Fundamentals
SPRY:
$542.20M
PG:
$344.65B
SPRY:
-$2.00
PG:
$6.62
SPRY:
5.45
PG:
4.04
SPRY:
8.84
PG:
6.47
SPRY:
$98.99M
PG:
$87.03B
SPRY:
$59.93M
PG:
$43.67B
SPRY:
-$194.60M
PG:
$21.25B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
SPRY vs. PG — Risk / Return Rank
SPRY
PG
SPRY vs. PG - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Silverback Therapeutics Inc (SPRY) and The Procter & Gamble Company (PG). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| SPRY | PG | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.90 | ||
| Sortino ratioReturn per unit of downside risk | -1.74 | ||
| Omega ratioGain probability vs. loss probability | 0.81 | 1.01 | -0.20 |
| Calmar ratioReturn relative to maximum drawdown | -0.96 | -0.06 | -0.90 |
| Martin ratioReturn relative to average drawdown | -1.42 | -0.10 | -1.32 |
Loading charts...
Drawdowns
SPRY vs. PG - Drawdown Comparison
The maximum SPRY drawdown since its inception was -95.20%, which is greater than PG's maximum drawdown of -54.25%. Use the drawdown chart below to compare losses from any high point for SPRY and PG.
Loading charts...
Drawdown Indicators
| SPRY | PG | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -95.20% | -54.25% | -40.95% |
Max Drawdown (1Y)Largest decline over 1 year | -71.47% | -15.52% | -55.95% |
Max Drawdown (3Y)Largest decline over 3 years | -72.04% | -21.15% | -50.89% |
Max Drawdown (5Y)Largest decline over 5 years | -90.62% | -23.77% | -66.85% |
Max Drawdown (10Y)Largest decline over 10 years | — | -23.77% | — |
Current DrawdownCurrent decline from peak | -90.96% | -15.35% | -75.61% |
Average DrawdownAverage peak-to-trough decline | -78.45% | -12.17% | -66.28% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 47.94% | 9.09% | +38.85% |
Volatility
SPRY vs. PG - Volatility Comparison
Silverback Therapeutics Inc (SPRY) has a higher volatility of 15.51% compared to The Procter & Gamble Company (PG) at 6.36%. This indicates that SPRY's price experiences larger fluctuations and is considered to be riskier than PG based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| SPRY | PG | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 15.51% | 6.36% | +9.15% |
Volatility (6M)Calculated over the trailing 6-month period | 49.67% | 15.67% | +34.00% |
Volatility (1Y)Calculated over the trailing 1-year period | 71.94% | 19.61% | +52.33% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 80.63% | 18.07% | +62.56% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 81.14% | 19.18% | +61.96% |
Dividends
SPRY vs. PG - Dividend Comparison
SPRY has not paid dividends to shareholders, while PG's dividend yield for the trailing twelve months is around 2.96%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
PG The Procter & Gamble Company | 2.96% | 2.91% | 2.36% | 2.55% | 2.38% | 2.08% | 2.24% | 2.37% | 3.09% | 2.98% | 3.18% | 3.31% |
SPRY Silverback Therapeutics Inc | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
SPRY vs. PG - Financials Comparison
This section allows you to compare key financial metrics between Silverback Therapeutics Inc and The Procter & Gamble Company. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
SPRY and PG have a correlation of 0.03, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
SPRY has higher volatility (15.51%) compared to PG (6.36%). In terms of maximum drawdown, SPRY dropped -95.20% vs PG's -54.25%.
PG currently has the higher Sharpe Ratio (-0.05 vs -0.95), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for SPRY and PG
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer